- Overview
- Product Description
- Packaging & Shipping
- Our Advantages
- FAQ
Basic Info.
Model NO.
001
Certification
GMP, ISO 9001, USP, BP
Suitable for
Elderly, Adult
State
Powder
Purity
>99%
Intermediate
Apixaban-2
Other Name
(Arry-470)
Sample
Free
Application
for Antibacteria
Heavy Metal
10ppm
Impurity
0.01%
Residual Solvent
Ethanol
Capacity
2500kg
Stock
2.00kg
Water
0.01%
Market
India
Ever Exported?
Yes
Experience
10years
Transport Package
Air
Specification
JP
Trademark
jianfeng
Origin
Shandong
Product Description
Our company sells more than 10 tons of Apixaban Intermediate to domestic export trading companies every year.
In recent years, we have started to do foreign market. Please contact me to get the factory price.
In addition to thisCAS 503612-47-3, we have the following apixaban intermediates.
| 1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl ester | 503614-91-3 | Apixaban intermediate | ||||
| Acetic acid, 2-chloro-2-[2-(4-methoxyphenyl)hydrazinylidene], ethyl ester | 27143-07-3 | Apixaban intermediate | ||||
| 2(1H)-pyridine,3-chloro-5,6-dihydro-1-(4-nitrophenyl) | 536760-29-9 | Apixaban intermediate | ||||
| 3-Morpholin-4-yl-1-[4-(2-oxopiperidin-1-yl)phenyl]-5,6-dihydro-1H-pyridin-2-one | 545445-44-1 | Apixaban intermediate | ||||
| 3-(4-Morpholinyl)-1-(4-nitrophenyl)-5,6-dihydro-2(1H)-pyridinone | 503615-03-0 | Apixaban intermediate | ||||
| Ethyl 1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3 | 536759-91-8 | Apixaban intermediate | ||||
| ethyl 6-(4-aMinophenyl)-1-(4-Methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate | 503615-07-4 | Apixaban intermediate | ||||
| 1-(4-AMinophenyl)-5,6-dihydro-3-(4-Morpholinyl)-2(1h)-pyridinone | 1267610-26-3 | Apixaban intermediate | ||||
| Ethyl (2Z)-chloro[(4-methoxyphenyl)hydrazono]ethanoate | 473927-63-8 | Apixaban intermediate | ||||
Apixaban is an anticoagulant used to reduce the risk of stroke and systemic embolism in patients with non valvular atrial fibrillation.
| Weight | Package |
| <25KG | By foil-alum bag/pap/bottle |
| ≥25kg | Package: 25kg/drum/bag or as your request |
Our manufacturer has fully implemented GMP/FDA/CEP management, GMPDA/CEP certifications are available.
Our manufactuer always takes innovation as the core, and attaches great importance to the improvement of its R & D comprehensive strength.
We are looking forward to your inquiry